FDA Approved: DOVATO — Original Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved Dovato, a fixed-dose combination of dolutegravir and lamivudine, under an original NDA for the treatment of HIV-1 infection in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dovato (dolutegravir/lamivudine)

Snippet

ORIG AP for DOVATO (DOLUTEGRAVIR SODIUM AND LAMIVUDINE)